National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 6013 [2019-03186]
Download as PDF
<![CDATA[
amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 84, No. 37 / Monday, February 25, 2019 / Notices
(CY). Information about the NACNHSC,
agendas, and materials for these
meetings can be found on the
NACNHSC website at https://
nhsc.hrsa.gov/about/national-advisorycouncil-nhsc/.
DATES: April 2–3, 2019, from 8:30 a.m.–
5:00 p.m. Eastern Time (ET) and
September 17–18, 2019, from 8:30 a.m.–
5:00 p.m. ET.
ADDRESSES: The April 2–3, 2019,
meeting will be held by webinar. The
September 17–18, 2019, meeting will be
held in-person at 5600 Fishers Lane,
Rockville, Maryland 20857. Additional
instructions for joining the meetings
either in person or remotely will be
posted on the NACNHSC website 30
business days before the date of the
meeting. For meeting information
updates, go to the NACNHSC website
meeting page at https://nhsc.hrsa.gov/
nac/meetings.html.
FOR FURTHER INFORMATION CONTACT:
Diane Fabiyi-King, Designated Federal
Official, Division of National Health
Service Corps; Bureau of Health
Workforce, HRSA, 5600 Fishers Lane,
Rockville, Maryland 20857; (301) 443–
3609; BHWNACNHSC@hrsa.gov.
SUPPLEMENTARY INFORMATION: The
NACNHSC was established by section
337 of the Public Health Service (PHS)
Act (42 U.S.C. 254j), as enacted by
Public Law (Pub. L.) 92–463, and as
subsequently amended, and advises the
Secretary of HHS (the Secretary) on
issues related to NHSC responsibilities.
During the CY 2019 meetings,
NACNHSC will discuss and draft policy
recommendations for submission to the
Secretary and the HRSA Administrator.
Agenda items are subject to change as
priorities dictate. Refer to the
NACNHSC website for any updated
information concerning the CY 2019
meetings.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meetings. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to the
NACNHSC should be sent to Diane
Fabiyi-King, DFO, at the contact
information listed above at least five
business days before the meeting dates.
Individuals who need special assistance
or another reasonable accommodation
should notify Diane Fabiyi-King, DFO at
the address and phone number listed
above at least 10 business days before
the meetings they wish to attend. Since
all in person meetings will occur in a
federal government building, attendees
VerDate Sep<11>2014
16:22 Feb 22, 2019
Jkt 247001
must go through a security check to
enter the building. Non-U.S. Citizen
attendees must notify HRSA of their
planned attendance at least 20 business
days prior to the meeting in order to
facilitate their entry into the building.
All attendees are required to present
government-issued identification prior
to entry.
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2019–03180 Filed 2–22–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Roybal
Centers Meeting: Coordinating Center (M3).
Date: March 14, 2019.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kimberly Firth, Ph.D.,
National Institutes of Health, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 20, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Clinical
Trial Applications Special Emphasis Panel.
Date: February 25, 2019.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7009, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–4721,
kozelp@niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 20, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–03186 Filed 2–22–19; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2019–03187 Filed 2–22–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 9990
6013
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 84, Number 37 (Monday, February 25, 2019)]
[Notices]
[Page 6013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03186]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Trial
Applications Special Emphasis Panel.
Date: February 25, 2019.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Peter J. Kozel, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7009, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-4721, kozelp@niddk.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: February 20, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-03186 Filed 2-22-19; 8:45 am]
BILLING CODE 4140-01-P
